These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 20625113)

  • 1. Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".
    Mohammed SF; Ohtani T; Korinek J; Lam CS; Larsen K; Simari RD; Valencik ML; Burnett JC; Redfield MM
    Circulation; 2010 Jul; 122(4):370-8. PubMed ID: 20625113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid signaling in transition to heart failure with normal ejection fraction.
    Shapiro BP; Owan TE; Mohammed S; Kruger M; Linke WA; Burnett JC; Redfield MM
    Hypertension; 2008 Feb; 51(2):289-95. PubMed ID: 18086943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
    Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
    Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
    Ohtani T; Ohta M; Yamamoto K; Mano T; Sakata Y; Nishio M; Takeda Y; Yoshida J; Miwa T; Okamoto M; Masuyama T; Nonaka Y; Hori M
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R946-54. PubMed ID: 17023667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats.
    Whaley-Connell AT; Habibi J; Aroor A; Ma L; Hayden MR; Ferrario CM; Demarco VG; Sowers JR
    Metabolism; 2013 Dec; 62(12):1761-71. PubMed ID: 24075738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.
    Saiki H; Moulay G; Guenzel AJ; Liu W; Decklever TD; Classic KL; Pham L; Chen HH; Burnett JC; Russell SJ; Redfield MM
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H392-H407. PubMed ID: 28550173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
    Methawasin M; Strom JG; Slater RE; Fernandez V; Saripalli C; Granzier H
    Circulation; 2016 Oct; 134(15):1085-1099. PubMed ID: 27630136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.
    Li X; Lu Q; Qiu Y; do Carmo JM; Wang Z; da Silva AA; Mouton A; Omoto ACM; Hall ME; Li J; Hall JE
    J Am Heart Assoc; 2021 Mar; 10(6):e018298. PubMed ID: 33719499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
    Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
    Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRD-733, a Novel PDE9 (Phosphodiesterase 9) Inhibitor, Reverses Pressure Overload-Induced Heart Failure.
    Richards DA; Aronovitz MJ; Liu P; Martin GL; Tam K; Pande S; Karas RH; Bloomfield DM; Mendelsohn ME; Blanton RM
    Circ Heart Fail; 2021 Jan; 14(1):e007300. PubMed ID: 33464954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.
    Brandt MM; Nguyen ITN; Krebber MM; van de Wouw J; Mokry M; Cramer MJ; Duncker DJ; Verhaar MC; Joles JA; Cheng C
    J Cell Mol Med; 2019 Oct; 23(10):6666-6678. PubMed ID: 31368189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress.
    Kumar A; Supowit S; Potts JD; DiPette DJ
    Physiol Rep; 2019 Nov; 7(21):e14269. PubMed ID: 31724338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.
    Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T
    Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mineralocorticoid receptor antagonists on left ventricular diastolic function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Kamiya T; Ohte N
    Heart Vessels; 2019 Apr; 34(4):597-606. PubMed ID: 30315496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction.
    Methawasin M; Strom J; Borkowski T; Hourani Z; Runyan R; Smith JE; Granzier H
    Circ Heart Fail; 2020 May; 13(5):e006609. PubMed ID: 32418479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction.
    Gao C; Xiong Z; Liu Y; Wang M; Wang M; Liu T; Liu J; Ren S; Cao N; Yan H; Drucker DJ; Rau CD; Yokota T; Huang J; Wang Y
    Circ Res; 2024 Aug; 135(5):614-628. PubMed ID: 39011638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.